It has also been shown that the therapeutic potential of MSCs that express high levels of Gal-9 is significantly higher than Gal-9 blocking MSCs in endotoxemia induced by LPS [229]. The gene discussed is LGALS9; the disease is serum lipopolysaccharide activity.